













Adrenergic receptor - Wikipedia, the free encyclopedia














/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Adrenergic_receptor";
		var wgTitle = "Adrenergic receptor";
		var wgAction = "view";
		var wgArticleId = "241017";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 281827300;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/
<!-- wikibits js -->



/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/ 
<!-- site js -->






if (wgNotice != '') document.writeln(wgNotice); Adrenergic receptor

From Wikipedia, the free encyclopedia

Jump to: navigation, search 




Adrenaline






Noradrenaline


The adrenergic receptors (or adrenoceptors) are a class of G protein-coupled receptors that are targets of the catecholamines. Adrenergic receptors specifically bind and are activated by their endogenous ligands, the catecholamines adrenaline (epinephrine) and noradrenaline (norepinephrine).
Many cells possess these receptors, and the binding of an agonist will generally cause a sympathetic response (ie the fight-or-flight response). For instance, the heart rate will increase and the pupils will dilate, energy will be mobilized, and blood flow diverted from other non-essential organs to skeletal muscle.




Contents


1 Subtypes

1.1 Roles in circulation
1.2 Comparison
1.3 α receptors

1.3.1 α1 receptor
1.3.2 α2 receptor


1.4 β receptors

1.4.1 β1 receptor
1.4.2 β2 receptor
1.4.3 β3 receptor




2 See also
3 References
4 Further reading
5 External links





//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>


[edit] Subtypes
There are two main groups of adrenergic receptors, α and β, with several subtypes.

α receptors have the subtypes α1 (a Gq coupled receptor) and α2 (a Gi coupled receptor). Phenylephrine is a selective agonist of the α receptor.
β receptors have the subtypes β1, β2 and β3. All three are linked to Gs proteins, which in turn are linked to adenylate cyclase. Agonist binding thus causes a rise in the intracellular concentration of the second messenger cAMP. Downstream effectors of cAMP include cAMP-dependent protein kinase (PKA), which mediates some of the intracellular events following hormone binding. Isoprenaline is a selective agonist.





Epinephrine binds its receptor, that associates with an heterotrimeric G protein. The G protein associates with adenylate cyclase that converts ATP to cAMP, spreading the signal (more details...)






The mechanism of adrenergic receptors. Adrenaline or noradrenaline are receptor ligands to either α1, α2 or β-adrenergic receptors. α1 couples to Gq, which results in increased intracellular Ca2+ which results in smooth muscle contraction. α2, on the other hand, couples to Gi, which causes a decrease of cAMP activity, resulting in e.g. smooth muscle relaxation. β receptors couple to Gs, and increases intracellular cAMP activity, resulting in e.g. heart muscle contraction, smooth muscle relaxation and glycogenolysis.



[edit] Roles in circulation
Adrenaline reacts with both α- and β-adrenoreceptors, causing vasoconstriction and vasodilation, respectively. Although α receptors are less sensitive to epinephrine, when activated, they override the vasodilation mediated by β-adrenoreceptors. The result is that high levels of circulating epinephrine cause vasoconstriction. At lower levels of circulating epinephrine, β-adrenoreceptor stimulation dominates, producing an overall vasodilation.

[edit] Comparison


Receptor type
Agonist potency order
Selected action
of agonist
Mechanism
Agonists
Antagonists


α1:
A, B, D†
norepinephrine ≥ epinephrine >> isoproterenol
smooth muscle contraction
Gq: phospholipase C (PLC) activated, IP3 and calcium up

(Alpha-1 agonists)

Noradrenaline
Phenylephrine
Methoxamine
Cirazoline
Xylometazoline


(Alpha-1 blockers)

Alfuzosin
Doxazosin
Phenoxybenzamine
Phentolamine
Prazosin
Tamsulosin
Terazosin




α2:
A, B, C
norepinephrine ≥ epinephrine >> isoproterenol
smooth muscle contraction and neurotransmitter inhibition
Gi: adenylate cyclase inactivated, cAMP down

(Alpha-2 agonists)

Dexmedetomidine
Clonidine
Lofexidine
Xylazine
Tizanidine
Guanfacine


(Alpha-2 blockers)

Yohimbine
Idazoxan




β1
isoprenaline > epinephrine = norepinephrine
heart muscle contraction
Gs: adenylate cyclase activated, cAMP up


Noradrenaline
Isoprenaline
Dobutamine


(Beta blockers)

Metoprolol
Atenolol




β2
isoprenaline > epinephrine >> norepinephrine
smooth muscle relaxation
Gs: adenylate cyclase activated, cAMP up
(Short/long)

Salbutamol (Albuterol in USA)
Bitolterol mesylate
Formoterol
Isoprenaline
Levalbuterol
Metaproterenol
Salmeterol
Terbutaline
Ritodrine


(Beta blockers)

Butoxamine
Propranolol




β3
isoprenaline = norepinephrine > epinephrine
Enhance lipolysis
Gs: adenylate cyclase activated, cAMP up


L-796568 [1]
Amibegron
Solabegron




SR 59230A




†There is no α1C receptor. At one time, there was a subtype known as C, but was found to be identical to one of the previously discovered subtypes. To avoid confusion, naming was continued with the letter D.

[edit] α receptors
α receptors have several functions in common, but also individual effects. Common (or still unspecified) effects include:

Vasoconstriction of arteries to heart (coronary artery).[2]
Vasoconstriction of veins[3]
Decrease motility of smooth muscle in gastrointestinal tract[4]


[edit] α1 receptor
Main article: Alpha-1 adrenergic receptor
Alpha1-adrenergic receptors are members of the G protein-coupled receptor superfamily. Upon activation, a heterotrimeric G protein, Gq, activates phospholipase C (PLC). The PLC cleaves phosphatidylinositol 4,5-biphosphate (PIP2) which in turn causes an increase in inositol triphosphate (IP3) and diacylglycerol (DAG). The former interacts with calcium channels of endoplasmic and sarcoplasmic retuculum thus changing the calcium content in a cell. This triggers all other effects.
Specific actions of the α1 receptor mainly involves smooth muscle contraction. It causes vasoconstriction in many blood vessels including those of the skin & gastrointestinal system and to kidney (renal artery)[5] and brain[6]. Other areas of smooth muscle contraction are:

ureter
vas deferens
hair (erector pili muscles)
uterus (when pregnant)
urethral sphincter
bronchioles (although minor to the relaxing effect of β2 receptor on bronchioles)
blood vessels of ciliary body (stimulation causes mydriasis)

Further effects include glycogenolysis and gluconeogenesis from adipose tissue[7] and liver, as well as secretion from sweat glands[7] and Na+ reabsorption from kidney.[7]
Antagonists may be used in hypertension.

[edit] α2 receptor
Main article: Alpha-2 adrenergic receptor
There are 3 highly homologous subtypes of α2 receptors: α2A, α2Β, and α2C.
Specific actions of the α2 receptor include:

inhibition of insulin release in pancreas.[7]
induction of glucagon release from pancreas.
contraction of sphincters of the gastrointestinal tract
negative feedback in the neuronal synapses


[edit] β receptors

[edit] β1 receptor
Main article: Beta-1 adrenergic receptor
Specific actions of the β1 receptor include:

Increase cardiac output, both by raising heart rate and increasing the volume expelled with each beat (increased ejection fraction).
Renin release from juxtaglomerular cells.[7]
Lipolysis in adipose tissue.[7]


[edit] β2 receptor
Main article: Beta-2 adrenergic receptor
The 3D crystallographic structure of the β2-adrenergic receptor has been determined (PDB 2R4R, 2R4S, 2RH1).[8][9][10]
Specific actions of the β2 receptor include:

Smooth muscle relaxation, e.g. in bronchi.[7]
Lipolysis in adipose tissue.[11]
Anabolism in skeletal muscle.[12][13]
Relax non-pregnant uterus
Relax detrusor urinae muscle‎ of bladder wall
Dilate arteries to skeletal muscle
Glycogenolysis and gluconeogenesis
Contract sphincters of GI tract
Thickened secretions from salivary glands.[7]
Inhibit histamine-release from mast cells
Increase renin secretion from kidney
Promotes insulin release from pancreatic beta cells


[edit] β3 receptor
Main article: Beta-3 adrenergic receptor
Specific actions of the β3 receptor include:

Enhancement of lipolysis in adipose tissue. However, acitvation of Beta-3 receptors often causes tremors, which is the paramount reason that Beta-3 activating pharmacological agents are not utilized as weight loss agents Clarify


[edit] See also

Beta adrenergic receptor kinase
Beta adrenergic receptor kinase-2


[edit] References


^ Nisoli E, Tonello C, Landi M, Carruba MO (1996). "Functional studies of the first selective β3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes". Mol. Pharmacol. 49 (1): 7–14. PMID 8569714. http://molpharm.aspetjournals.org/cgi/content/abstract/49/1/7. 
^ Woodman OL, Vatner SF (1987). "Coronary vasoconstriction mediated by α1- and α2-adrenoceptors in conscious dogs". Am. J. Physiol. 253 (2 Pt 2): H388–93. PMID 2887122. http://ajpheart.physiology.org/cgi/content/abstract/253/2/H388. 
^ Elliott J (1997). "Alpha-adrenoceptors in equine digital veins: evidence for the presence of both α1- and α2-receptors mediating vasoconstriction". J. Vet. Pharmacol. Ther. 20 (4): 308–17. doi:10.1046/j.1365-2885.1997.00078.x. PMID 9280371. 
^ Sagrada A, Fargeas MJ, Bueno L (1987). "Involvement of α1 and α2 adrenoceptors in the postlaparotomy intestinal motor disturbances in the rat". Gut 28 (8): 955–9. PMID 2889649. 
^ Schmitz JM, Graham RM, Sagalowsky A, Pettinger WA (1981). "Renal α1 and α2 adrenergic receptors: biochemical and pharmacological correlations". J. Pharmacol. Exp. Ther. 219 (2): 400–6. PMID 6270306. http://jpet.aspetjournals.org/cgi/content/abstract/219/2/400. 
^ Circulation & Lung Physiology I M.A.S.T.E.R. Learning Program, UC Davis School of Medicine
^ a b c d e f g h Fitzpatrick, David; Purves, Dale; Augustine, George (2004). "Table 20:2". Neuroscience (Third Edition ed.). Sunderland, Mass: Sinauer. ISBN 0-87893-725-0. 
^ Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VR, Sanishvili R, Fischetti RF, Schertler GF, Weis WI, Kobilka BK (2007). "Crystal structure of the human β2-adrenergic G-protein-coupled receptor". Nature 450 (7168): 383–7. doi:10.1038/nature06325. PMID 17952055. 
^ Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC (2007). "High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor". Science 318 (5854): 1258–65. doi:10.1126/science.1150577. PMID 17962520. 
^ Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Yao XJ, Weis WI, Stevens RC, Kobilka BK (2007). "GPCR engineering yields high-resolution structural insights into β2-adrenergic receptor function". Science 318 (5854): 1266–73. doi:10.1126/science.1150609. PMID 17962519. 
^ Large V, Hellström L, Reynisdottir S, et al (December 1997). "Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function". J. Clin. Invest. 100 (12): 3005–13. doi:10.1172/JCI119854. PMID 9399946. 
^ Kline WO, Panaro FJ, Yang H, Bodine SC (February 2007). "Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol". J. Appl. Physiol. 102 (2): 740–7. doi:10.1152/japplphysiol.00873.2006. PMID 17068216. 
^ Kamalakkannan G, Petrilli CM, George I, et al (April 2008). "Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure". J. Heart Lung Transplant. 27 (4): 457–61. doi:10.1016/j.healun.2008.01.013. PMID 18374884. 



[edit] Further reading

Rang HP, Dale MM, Ritter JM, Moore PK (2003). "Ch. 11". Pharmacology. Elsevier Churchill Livingstone. ISBN 0-443-07145-4. 
Rang HP, Dale MM, Ritter JM, Flower RJ (2007). "Ch. 11". Rang and Dale's Pharmacology. Elsevier Churchill Livingstone. pp. 169–170. ISBN 0-443-06911-5. 


[edit] External links

The Adrenergic Receptors
"Adrenoceptors". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. http://www.iuphar-db.org/GPCR/ChapterMenuForward?chapterID=1274. 
Basic Neurochemistry: α- and β-Adrenergic Receptors
Brief overview of functions of the beta-3 receptor
Theory of receptor activation
Desensitization of beta-1-receptors
UMich Orientation of Proteins in Membranes protein/pdbid-2rh1 - 3D structure of beta-2 adrenergic receptor in membrane








v • d • e

Adrenergic agonists (models/most important in small caps)





α





α1


METHOXAMINE · Methylnorepinephrine · Oxymetazoline · PHENYLEPHRINE · Metaraminol







α2


4-NEMD · CLONIDINE · Guanfacine · Guanabenz · Guanoxabenz · Guanethidine · Xylazine · METHYLDOPA · Apraclonidine · Brimonidine · Detomidine · Dexmedetomidine · Lofexidine · Romifidine · Tizanidine · Xylometazoline







Undetermined/
unsorted


Amidephrine · Amitraz · Anisodamine · Ergotamine · Indanidine · Medetomidine · Mephentermine · Midodrine · Mivazerol · Naphazoline · Norfenefrine · Octopamine · Phenylpropanolamine · Rilmenidine · Synephrine · Talipexole · Tetrahydrozoline · Xylometazoline









β





β1


DOBUTAMINE · Dopamine · Denopamine · Xamoterol







β2


Short acting β2-agonists: SALBUTAMOL (ALBUTEROL)/Levosalbutamol · Fenoterol · TERBUTALINE · Pirbuterol · Procaterol · Bitolterol · Rimiterol · Carbuterol · Tulobuterol · Reproterol · Dopexamine
Long acting β2-agonists (LABA): Arformoterol · Bambuterol · Clenbuterol · Formoterol · Salmeterol
Orciprenaline (metaproterenol) · Ritodrine · Hexoprenaline · Indacaterol







β3


Amibegron · Solabegron







Undetermined/
unsorted


Arbutamine · Befunolol · Isoetarine · Isoxsuprine · Nylidrin · Oxyfedrine · Prenalterol · Ractopamine · Bromoacetylalprenololmenthane · Broxaterol · Cimaterol · Higenamine · Mabuterol · Methoxyphenamine · Tretoquinol · Zinterol







Nonselective β


ISOPRENALINE (ISOPROTERENOL)









α and β

Epinephrine (α1+2, β1+2) · Norepinephrine (α1+2, β1) · Cirazoline · Etilefrine · Ephedrine · Pseudoephedrine






Indirect

presynaptic norepinephrine release: Amphetamine · Tyramine · Ephedrine  · Pseudoephedrine
norepinephrine reuptake inhibitor: Cocaine







see also monoamine oxidase inhibitor













v • d • e

Transmembrane receptor: G protein-coupled receptors





Class A: Rhodopsin like





Adrenergic


α1 (A, B, D) · α2 (A, B, C) · β1 · β2 · β3







Eicosanoid


CysLT (1, 2) · LTB4 (1, 2) · FPRL1 · OXE · Prostaglandin (DP, EP (1, 2, 3, 4), PGF) · Prostacyclin · Thromboxane







Neuropeptide


B/W (1, 2) · FF (1, 2) · S · Y (1, 2, 4, 5) · Neuromedin (B, U (1, 2)) · Neurotensin (1, 2)







Orphan


GPR (1, 3, 4, 6, 12, 15, 17, 18, 19, 20, 21, 22, 23, 25, 26, 27, 31, 32, 33, 34, 35, 37, 39, 42, 44, 45, 50, 52, 55, 61, 62, 63, 65, 68, 75, 77, 78, 82, 83, 84, 85, 87, 88, 92, 101, 103, 119, 120, 132, 135, 139, 141, 142, 146, 148, 149, 150, 151, 152, 153, 160, 161, 162, 171, 173, 174, 176, 177, 182)







Purinergics


Adenosine (A1, A2a, A2b, A3) · P2Y (1, 2, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14)







Serotonin


(all but 5-HT3) 5-HT1 (A, B, D, E, F) · 5-HT2 (A, B, C) · 5-HT (4, 5A, 6, 7)







Other


Acetylcholine (M1, M2, M3, M4, M5) · Adrenomedullin · Anaphylatoxin (C3a, C5a) · Angiotensin (1, 2) · Apelin · Bile acid · Bombesin (BRS3, GRPR, NMBR) · Bradykinin (B1, B2) · Cannabinoid (CB1, CB2) · Chemokine · Cholecystokinin (A, B) · Dopamine (D1, D2, D3, D4, D5) · EBI2 · Endothelin (A, B) · Estrogen · Formyl peptide (1, L1, L2) · Free fatty acid (1, 2, 3, 4) · FSH · Galanin (1, 2, 3) · Gonadotropin-releasing hormone (1, 2) · GHB receptor · Ghrelin · Histamine (H1, H2, H3, H4) · Kisspeptin · Luteinizing hormone/choriogonadotropin · Lysophospholipid (1, 2, 3, 4, 5, 6, 7, 8) · MAS (1, 1L, D, E, F, G, X1, X2, X3, X4) · Melanocortin (1, 2, 3, 4, 5) · MCHR (1, 2) · Melatonin (1A, 1B) · Motilin · Opioid (Delta, Kappa, Mu, Nociceptin & Zeta, but not Sigma) · Olfactory · Opsin (3, 4, 5, 1LW, 1MW, 1SW, RGR, RRH) · Orexin (1, 2) · Oxytocin · Oxoglutarate · PAF · Prokineticin (1, 2) · Prolactin-releasing peptide · Protease-activated (1, 2, 3, 4) · Relaxin (1, 2, 3, 4) · Somatostatin (1, 2, 3, 4, 5) · SREB · Succinate · TAAR (1, 2, 3, 5, 6, 8, 9) · Tachykinin (1, 2, 3) · Thyrotropin · Thyrotropin-releasing hormone · Urotensin-II · Vasopressin (1A, 1B, 2)









Class B: Secretin like





Orphan


GPR (56, 64, 97, 98, 110, 111, 112, 113, 114, 115, 116, 123, 124, 125, 126, 128, 133, 143, 144, 157)







Other


Brain-specific angiogenesis inhibitor (1, 2, 3) · Cadherin (1, 2, 3) · Calcitonin · CALCRL · CD97 · Corticotropin-releasing hormone (1, 2) · EMR (1, 2, 3) · Glucagon (GR, GIPR, GLP1R, GLP2R) · Growth hormone releasing hormone · PACAPR1 · GPR · Latrophilin (1, 2, 3, ELTD1) · Parathyroid hormone (1, 2) · Secretin · Vasoactive intestinal peptide (1, 2)









Class C: Metabotropic
glutamate / pheromone





Taste


TAS1R (1, 2, 3) · TAS2R (1, 3, 4, 5, 8, 9, 10, 12, 13, 14, 16, 38, 39, 40, 41, 43, 44, 45, 46, 47, 48, 49, 50)







Other


Calcium-sensing receptor · GABA B (1, 2) · Glutamate receptor (Metabotropic glutamate (1, 2, 3, 4, 5, 6, 7, 8)) · GPRC6A · GPR (156, 158, 179) · RAIG (1, 2, 3, 4)









Frizzled / Smoothened

Frizzled (1, 2, 3, 4, 5, 6, 7, 8, 9, 10) · Smoothened









Retrieved from "http://en.wikipedia.org/wiki/Adrenergic_receptor"
Categories: Adrenergic receptors | G protein coupled receptors 






Views


Article
Discussion
Edit this page
History 



Personal tools


Log in / create account






 if (window.isMSIE55) fixalpha(); 

Navigation


Main page
Contents
Featured content
Current events
Random article




Search




 
				




Interaction


About Wikipedia
Community portal
Recent changes
Contact Wikipedia
Donate to Wikipedia
Help




Toolbox


What links here
Related changes
Upload file
Special pages
Printable version Permanent linkCite this page 



Languages


Deutsch
Español
Français
Italiano
日本語
Polski
Português
Русский
Suomi









 This page was last modified on 5 April 2009, at 03:08 (UTC).
All text is available under the terms of the GNU Free Documentation License. (See Copyrights for details.)  Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a U.S. registered 501(c)(3) tax-deductible nonprofit charity.
Privacy policy
About Wikipedia
Disclaimers



if (window.runOnloadHook) runOnloadHook();
